DK1434570T3 - Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin - Google Patents

Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin

Info

Publication number: DK1434570T3
Authority: DK; Denmark
Prior art keywords: tetrahydroisoquinol; methanesulfonamido; quinazoline; dimethoxy; pyridyl
Prior art date: 2001-10-11

Application number

DK02775048T

Other languages

Danish (da)

English (en)

Inventor

John D Davis

Michael J Humphrey

Ross J Macrae

Janet S Smith

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-11

Filing date

2002-09-30

Publication date

2005-11-07

2002-09-30 Application filed by Pfizer filed Critical Pfizer

2005-11-07 Application granted granted Critical

2005-11-07 Publication of DK1434570T3 publication Critical patent/DK1434570T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

DK02775048T 2001-10-11 2002-09-30 Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin DK1434570T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0124455.7A GB0124455D0 (en)	2001-10-11	2001-10-11	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
DK1434570T3 true DK1434570T3 (da)	2005-11-07

Family

ID=9923660

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02775048T DK1434570T3 (da)	2001-10-11	2002-09-30	Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin

Country Status (32)

Country	Link
EP (1)	EP1434570B8 (xx)
JP (1)	JP4131471B2 (xx)
KR (1)	KR20050032510A (xx)
CN (1)	CN1568180A (xx)
AP (1)	AP2004003001A0 (xx)
AR (1)	AR036782A1 (xx)
AT (1)	ATE303135T1 (xx)
BR (1)	BR0213196A (xx)
CA (1)	CA2461168A1 (xx)
CO (1)	CO5560534A2 (xx)
DE (1)	DE60205925T2 (xx)
DK (1)	DK1434570T3 (xx)
DO (1)	DOP2002000464A (xx)
EA (1)	EA006168B1 (xx)
ES (1)	ES2246017T3 (xx)
GB (1)	GB0124455D0 (xx)
GT (1)	GT200200184A (xx)
HR (1)	HRP20040261A2 (xx)
HU (1)	HUP0600064A3 (xx)
IL (1)	IL160969A0 (xx)
IS (1)	IS7179A (xx)
MA (1)	MA27075A1 (xx)
MX (1)	MXPA04003293A (xx)
NO (1)	NO20041520L (xx)
OA (1)	OA12709A (xx)
PA (1)	PA8556001A1 (xx)
PE (1)	PE20030551A1 (xx)
PL (1)	PL369666A1 (xx)
SV (1)	SV2004001279A (xx)
UY (1)	UY27477A1 (xx)
WO (1)	WO2003032956A1 (xx)
ZA (1)	ZA200401976B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0317663D0 (en) *	2003-07-29	2003-09-03	Astrazeneca Ab	Pharmaceutical composition
DK2970123T3 (da) *	2013-03-14	2019-10-21	Amgen Inc	Salt af omecamtiv mecarbil og fremgangsmåde til fremstilling heraf
KR101943592B1 (ko)	2017-08-31	2019-01-30	조현우	데이터 마이닝 기법을 이용한 전자가계부 시스템

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE104826T1 (de) *	1990-07-02	1994-05-15	Bend Res Inc	Asymmetrische mikroporoese kuegelchen fuer regulierbare freigabe.
FR2752737B1 (fr) *	1996-08-29	1998-10-02	Synthelabo	Comprime a liberation controlee de chlorhydrate d'alfuzosine
GB9700504D0 (en) *	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds
IL141235A (en) *	2000-02-09	2012-04-30	Novartis Int Pharm Ltd	Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
PT1268468E (pt) *	2000-03-03	2004-01-30	Pfizer	Mesilato de 4-amino-6,7dimetoxi-2- (5-metanossulfonamido-1,2,3,4-tetra-hidro-2-isoquinolil)5-5(2-piridil-quinazolina e polimorfos

2001
- 2001-10-11 GB GBGB0124455.7A patent/GB0124455D0/en not_active Ceased
2002
- 2002-09-12 DO DO2002000464A patent/DOP2002000464A/es unknown
- 2002-09-17 GT GT200200184A patent/GT200200184A/es unknown
- 2002-09-30 KR KR1020047005316A patent/KR20050032510A/ko not_active Application Discontinuation
- 2002-09-30 WO PCT/IB2002/004040 patent/WO2003032956A1/en active IP Right Grant
- 2002-09-30 CN CNA02820042XA patent/CN1568180A/zh active Pending
- 2002-09-30 CA CA002461168A patent/CA2461168A1/en not_active Abandoned
- 2002-09-30 HU HU0600064A patent/HUP0600064A3/hu unknown
- 2002-09-30 PL PL02369666A patent/PL369666A1/xx not_active Application Discontinuation
- 2002-09-30 EA EA200400431A patent/EA006168B1/ru not_active IP Right Cessation
- 2002-09-30 OA OA1200400094A patent/OA12709A/en unknown
- 2002-09-30 AT AT02775048T patent/ATE303135T1/de not_active IP Right Cessation
- 2002-09-30 ES ES02775048T patent/ES2246017T3/es not_active Expired - Lifetime
- 2002-09-30 AP APAP/P/2004/003001A patent/AP2004003001A0/en unknown
- 2002-09-30 EP EP02775048A patent/EP1434570B8/en not_active Expired - Lifetime
- 2002-09-30 DE DE60205925T patent/DE60205925T2/de not_active Expired - Lifetime
- 2002-09-30 IL IL16096902A patent/IL160969A0/xx unknown
- 2002-09-30 DK DK02775048T patent/DK1434570T3/da active
- 2002-09-30 MX MXPA04003293A patent/MXPA04003293A/es active IP Right Grant
- 2002-09-30 JP JP2003535760A patent/JP4131471B2/ja not_active Expired - Fee Related
- 2002-09-30 BR BR0213196-0A patent/BR0213196A/pt not_active IP Right Cessation
- 2002-10-09 PE PE2002000996A patent/PE20030551A1/es not_active Application Discontinuation
- 2002-10-09 UY UY27477A patent/UY27477A1/es not_active Application Discontinuation
- 2002-10-09 AR ARP020103805A patent/AR036782A1/es unknown
- 2002-10-10 PA PA20028556001A patent/PA8556001A1/es unknown
- 2002-10-10 SV SV2002001279A patent/SV2004001279A/es not_active Application Discontinuation
2004
- 2004-03-11 IS IS7179A patent/IS7179A/is unknown
- 2004-03-11 ZA ZA200401976A patent/ZA200401976B/en unknown
- 2004-03-17 HR HR20040261A patent/HRP20040261A2/hr not_active Application Discontinuation
- 2004-03-18 CO CO04025929A patent/CO5560534A2/es not_active Application Discontinuation
- 2004-04-05 NO NO20041520A patent/NO20041520L/no unknown
- 2004-04-08 MA MA27623A patent/MA27075A1/fr unknown

Also Published As

Publication number	Publication date
EP1434570B1 (en)	2005-08-31
AR036782A1 (es)	2004-10-06
SV2004001279A (es)	2004-02-19
CA2461168A1 (en)	2003-04-24
MXPA04003293A (es)	2004-07-23
EA200400431A1 (ru)	2004-08-26
DOP2002000464A (es)	2003-04-15
GB0124455D0 (en)	2001-12-05
HRP20040261A2 (en)	2004-08-31
IS7179A (is)	2004-03-11
UY27477A1 (es)	2003-05-30
NO20041520L (no)	2004-04-05
GT200200184A (es)	2003-05-23
JP2005507909A (ja)	2005-03-24
WO2003032956A1 (en)	2003-04-24
CO5560534A2 (es)	2005-09-30
BR0213196A (pt)	2004-08-31
PE20030551A1 (es)	2003-06-26
EP1434570A1 (en)	2004-07-07
AP2004003001A0 (en)	2004-03-31
IL160969A0 (en)	2004-08-31
CN1568180A (zh)	2005-01-19
HUP0600064A3 (en)	2007-02-28
PA8556001A1 (es)	2003-07-28
PL369666A1 (en)	2005-05-02
DE60205925T2 (de)	2006-06-08
MA27075A1 (fr)	2004-12-20
DE60205925D1 (de)	2005-10-06
EA006168B1 (ru)	2005-10-27
ZA200401976B (en)	2004-07-12
HUP0600064A2 (en)	2006-06-28
ATE303135T1 (de)	2005-09-15
EP1434570B8 (en)	2005-10-26
OA12709A (en)	2006-06-26
KR20050032510A (ko)	2005-04-07
ES2246017T3 (es)	2006-02-01
JP4131471B2 (ja)	2008-08-13

Publication	Publication Date	Title
DK1292594T3 (da)	2004-12-06	Quinazolinderivater til behandling af tumorer
IS6524A (is)	2002-08-23	5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar
ATE446093T1 (de)	2009-11-15	Substituierte chinazolin-derivate als aurora- kinase inhibitoren
IS7227A (is)	2004-04-19	Salt form af E-2-metoxí-N-(3-(4-(3-metýl-pýridín-3-yloxýl)-fenýlamínó)-kínasólín-6-yl)-allýl)-asetamíð, framleiðsla þess og notkun gegn krabbameini
DK1762567T3 (da)	2012-06-25	Pyrazolderivater til behandling af HIV
IS6968A (is)	2003-09-26	Nýir týrósínkínasa tálmar
DK1432707T3 (da)	2012-06-11	Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme
DK1417180T3 (da)	2007-04-10	Fremstilling af aminopyrimidinforbindelser
DK1448235T3 (da)	2007-07-02	Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
DZ3425A1 (fr)	2002-03-21	Derives de quinolinone en tant qu'inhibiteurs kinases de tyrosine
DK1202746T3 (da)	2007-01-02	NSAID- og EGFR-kinaseinhibitorerholdigt præparat til behandling eller inhibering af colonpolypper og colorektal cancer
DK1259512T3 (da)	2003-12-29	Pteridinforbindelser til behandling af psoreasis
DK1401451T3 (da)	2010-03-29	Quinazolinderivater, der fremmer frigivelsen af parathyroidhormon
EE200300491A (et)	2004-02-16	6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena
NO20035540D0 (no)	2003-12-11	Eksoterme preparater til behandling av ektoparasitter
DK1434570T3 (da)	2005-11-07	Farmaceutiske formuleringer til kontrolleret frigivelse af 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazolin
NO20024195D0 (no)	2002-09-03	4-amino-6,7-dimetoksy-2-(5-metansulfonamido-1,2,3,4- tetrahydroisoquinol-2-yl)-5-(2-pyridinyl)quinazolin-mesylat samtpolymorfer
SE0001373D0 (sv)	2000-04-13	NPY Y1 receptor agonists and antagonists
DK1281707T3 (da)	2005-05-02	Fremgangsmåde til fremstilling af 5-substituerede isobenzenfuraner
DK1345605T3 (da)	2005-10-10	Varmformet lægemiddelsammensætning til styret afgivelse af perindopril
DK1363928T3 (da)	2005-12-12	Fremgangsåde til fremstilling af (E)-5-(2-bromvinyl)-2'-deoxyuridin
DK1451177T3 (da)	2007-07-02	Substituerede 2-pyrrolidin-2-yl-1H-indol-derivater til behandling af migræne
DK1153015T3 (da)	2005-02-07	Pyrimidin-2,4,6-trioner som inhibitorer af matrix-metalloproteinaser